Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gebhard Thoma

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Medicinal Chemistry|November 28, 2023
Discovery of Amino Alcohols as Highly Potent, Selective, and Orally Efficacious Inhibitors of Leukotriene A4 HydrolaseGebhard Thoma, Christian Markert, Rainer Lueoend, et al.
Journal of Medicinal Chemistry|April 2, 2004
Orally bioavailable competitive CCR5 antagonistsGebhard Thoma, François Nuninger, Marc Schaefer, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2014
Syk inhibitors with high potency in presence of bloodGebhard Thoma, Joachim Blanz, Peter Bühlmayer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 7, 2010
Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1Paolo Fiorina, Mollie Jurewicz, Andrea Vergani, et al.
Experimental Dermatology|May 25, 2024
Modelling atopic dermatitis in healthy human skin for the characterization of topical compoundsFeriel Hacini-Rachinel, Alice Hauchard, Sandro Bruno, et al.
The Journal of Clinical Investigation|December 19, 2002
Removal of anti-Galalpha1,3Gal xenoantibodies with an injectable polymerAndreas G Katopodis, Richard G Warner, Rudolf O Duthaler, et al.
Journal of Medicinal Chemistry|February 16, 2021
Discovery of LYS006, a Potent and Highly Selective Inhibitor of Leukotriene A<sub>4</sub> HydrolaseChristian Markert, Gebhard Thoma, Honnappa Srinivas, et al.
Journal of Medicinal Chemistry|February 17, 2025
Discovery of GJG057, a Potent and Highly Selective Inhibitor of Leukotriene C4 SynthaseGebhard Thoma, Wolfgang Miltz, Rudolf Waelchli, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Medicinal Chemistry|November 28, 2023
Discovery of Amino Alcohols as Highly Potent, Selective, and Orally Efficacious Inhibitors of Leukotriene A4 HydrolaseGebhard Thoma, Christian Markert, Rainer Lueoend, et al.
Journal of Medicinal Chemistry|April 2, 2004
Orally bioavailable competitive CCR5 antagonistsGebhard Thoma, François Nuninger, Marc Schaefer, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2014
Syk inhibitors with high potency in presence of bloodGebhard Thoma, Joachim Blanz, Peter Bühlmayer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 7, 2010
Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1Paolo Fiorina, Mollie Jurewicz, Andrea Vergani, et al.
Experimental Dermatology|May 25, 2024
Modelling atopic dermatitis in healthy human skin for the characterization of topical compoundsFeriel Hacini-Rachinel, Alice Hauchard, Sandro Bruno, et al.
The Journal of Clinical Investigation|December 19, 2002
Removal of anti-Galalpha1,3Gal xenoantibodies with an injectable polymerAndreas G Katopodis, Richard G Warner, Rudolf O Duthaler, et al.
Journal of Medicinal Chemistry|February 16, 2021
Discovery of LYS006, a Potent and Highly Selective Inhibitor of Leukotriene A<sub>4</sub> HydrolaseChristian Markert, Gebhard Thoma, Honnappa Srinivas, et al.
Journal of Medicinal Chemistry|February 17, 2025
Discovery of GJG057, a Potent and Highly Selective Inhibitor of Leukotriene C4 SynthaseGebhard Thoma, Wolfgang Miltz, Rudolf Waelchli, et al.
Pageof 3